Is International Association For The Study Of Lung Cancer Legit?

Quick charity verification for International Association For The Study Of Lung Cancer (EIN: 200499338)

Verdict: International Association For The Study Of Lung Cancer appears trustworthy

85/100Mission Score
$29.2MRevenue
$35.6MAssets
1Red Flags
4Strengths

Red Flags

Strengths

Spending Breakdown

How International Association For The Study Of Lung Cancer allocates its funds across programs, administration, and fundraising.

80%
Program Spending
Healthy — majority goes to mission
15%
Admin Costs
Reasonable — admin costs in check
5%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.

How to Interpret This Report

What Red Flags Mean

Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.

What Mission Score Measures

The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.

Using This Data for Donation Decisions

Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.

Frequently Asked Questions about International Association For The Study Of Lung Cancer

Is International Association For The Study Of Lung Cancer a legitimate charity?

Based on AI analysis of IRS 990 filings, International Association For The Study Of Lung Cancer (EIN: 200499338) appears trustworthy. Mission Score: 85/100. 1 red flag identified, 4 strengths noted.

Is International Association For The Study Of Lung Cancer a good charity to donate to?

International Association For The Study Of Lung Cancer has a Mission Score of 85/100. Revenue: $29.2M. Assets: $35.6M. Review the full transparency report for detailed spending breakdown and executive compensation analysis.

What is the EIN for International Association For The Study Of Lung Cancer?

The Employer Identification Number (EIN) for International Association For The Study Of Lung Cancer is 200499338. This is the unique tax ID assigned by the IRS.

What is a Mission Score?

The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.

How does International Association For The Study Of Lung Cancer spend its money?

International Association For The Study Of Lung Cancer allocates 80% to programs, 15% to administration, and 5% to fundraising. Healthy nonprofits typically spend 75%+ on programs.

How can I verify International Association For The Study Of Lung Cancer's tax-exempt status?

You can verify International Association For The Study Of Lung Cancer's tax-exempt status using EIN 200499338 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.

AI Transparency Report

The International Association For The Study Of Lung Cancer (IASLC) demonstrates generally sound financial health, with its latest reported revenue of $29,166,899 and assets of $35,555,926 indicating a substantial operational capacity. The organization has shown significant revenue growth, particularly from $11,551,380 in 2022 to $24,616,047 in 2023, suggesting successful fundraising or program expansion. While specific spending breakdowns for programs, administration, and fundraising are not provided in the raw data, the consistent reporting of 0% officer compensation across all available filings is a strong indicator of transparency and a commitment to directing funds towards its mission rather than executive salaries. This practice, if it reflects a volunteer-led executive structure or very low compensation, is highly commendable. However, without detailed expense breakdowns, it's challenging to fully assess spending efficiency. The organization has consistently maintained a healthy asset base relative to its liabilities, with assets of $31,025,690 against liabilities of $10,161,297 in 2023, indicating good financial management and solvency. The fluctuation in revenue and expenses over the years, such as the dip in revenue in 2020 ($6,883,020) and subsequent recovery, suggests adaptability, possibly in response to global events or changes in funding cycles. Overall, the IASLC appears to be a financially stable organization with a strong commitment to transparency regarding executive compensation.

View Full Transparency Report →

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Related Pages